Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedUpdated the Publications entry to include the Lancet Neurology ADAPT study citation with an erratum and revision v3.5.2; the older v3.5.0 entry was removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedNapoli, Italy (80131) site name changed to Naples, Italy (80131). Expanded Access note 'Available outside the clinical trial' added and page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check45 days agoChange DetectedSite revision information updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added and the older funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedA site-wide notice about government funding status and NIH Clinical Center operations has been added. The page revision version was updated from 3.4.0 to 3.4.1.SummaryDifference0.3%

- Check88 days agoChange DetectedThe page now shows a glossary and the field 'Last Update Submitted that Met QC Criteria.' A new revision label 'v3.4.0' was added, replacing 'v3.3.4,' and there are capitalization updates to 'No FEAR Act' data.SummaryDifference0.2%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.